返回 Agenda
Session 4: High-Quality Real World Data (RWD) in Decision Making
Session Chair(s)
Susan Longman
Head Regulatory Affairs Region Europe
Novartis Pharma AG, Switzerland
Session 4: High-Quality Real World Data (RWD) in Decision Making
Speaker(s)
Registry Initiatives Across Europe
Xavier Kurz, MD, PhD, MSc
European Medicines Agency, Netherlands
Head of Data Analytics Workstream
Karin Van Baelen, PharmD
Janssen, Belgium
Head, Global Regulatory Affairs
Trusting the Data: Quality, Ethics, Privacy
Jesper Kjær, MS
Danish Medicines Agency DKMA, Denmark
Director of DKMA Data Analytics Centre